(19)
(11) EP 4 536 181 A1

(12)

(43) Date of publication:
16.04.2025 Bulletin 2025/16

(21) Application number: 23738387.2

(22) Date of filing: 08.06.2023
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 9/28(2006.01)
A61K 47/10(2017.01)
A61P 25/14(2006.01)
A61K 9/20(2006.01)
A61K 31/473(2006.01)
A61K 47/38(2006.01)
A61P 25/28(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 47/10; A61K 47/38; A61K 9/0004; A61K 9/2866; A61K 9/2086; A61P 25/14; A61P 25/28; A61K 31/4745
(86) International application number:
PCT/US2023/068129
(87) International publication number:
WO 2023/240186 (14.12.2023 Gazette 2023/50)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 08.06.2022 US 202217835435

(71) Applicant: Auspex Pharmaceuticals, Inc.
Parsippany NJ 07054 (US)

(72) Inventors:
  • SHAH, Parag
    Parsippany, New Jersey 07054 (US)
  • JOSHI, Mayank
    Parsippany, New Jersey 07054 (US)
  • PATTANAYEK, Soumen
    Parsippany, New Jersey 07054 (US)
  • PATEL, Divyang
    Parsippany, New Jersey 07054 (US)
  • PANDITA, Sandeep
    Parsippany, New Jersey 07054 (US)

(74) Representative: D Young & Co LLP 
3 Noble Street
London EC2V 7BQ
London EC2V 7BQ (GB)

   


(54) OSMOTIC DOSAGE FORMS COMPRISING DEUTETRABENAZINE AND METHODS OF USE THEREOF